Analytical Data
-
基因名
ARL6IP
- Application
-
别名
ARL6IP1; ARL6IP; ARMER; KIAA0069; ADP-ribosylation factor-like Protein 6-interacting Protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q15041
-
表达区间
1-203aa
-
氨基酸序列
MAEGDNRSTNLLAAETASLEEQLQGWGEVMLMADKVLRWERAWFPPAIMGVVSLVFLIIYYLDPSVLSGVSCFVMFLCLADYLVPILAPRIFGSNKWTTEQQQRFHEICSNLVKTRRRAVGWWKRLFTLKEEKPKMYFMTMIVSLAAVAWVGQQVHNLLLTYLIVTSLLLLPGLNQHGIILKYIGMAKREINKLLKQKEKKNE
-
分子量
48.07 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ARL6IP (ADP-ribosylation factor-like 6 interacting protein) is a protein implicated in several cellular processes, including vesicle trafficking, cytoskeletal organization, and cell signaling. It is known to interact with various cellular components, potentially influencing pathways related to cell proliferation, differentiation, and apoptosis. The study of ARL6IP is particularly significant in the context of cancer research, where its aberrant expression and function have been associated with tumor progression and metastasis. Researchers have been exploring the mechanisms by which ARL6IP regulates these cellular processes, aiming to elucidate its role in maintaining cellular homeostasis and its potential as a therapeutic target. Advances in recombinant protein technology have enabled the production of ARL6IP for in-depth biochemical and structural characterization. By studying the properties and interactions of ARL6IP in vitro and in vivo, scientists hope to gain insights into its functional roles and its contributions to pathological states, particularly in the context of cancer. This research not only enhances the understanding of ARL6IP's biological significance but also holds promise for the development of novel diagnostic and therapeutic strategies targeting ARL6IP-related pathways.
